Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis and Oxycodone on Abuse Liability and Analgesia
NCT03679949Phase 1Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Apr 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabis in pain and opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Apr 2019; status: completed.
02
Drugs
cannabis
03
Conditions
painopioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03679949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03679949.